- Home
- KNSA vs BAK Comparison
KNSA vs BAK Comparison
Compare KNSA & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- BAK
- Stock Information
- Founded
- KNSA 2015
- BAK 1972
- Country
- KNSA United Kingdom
- BAK Brazil
- Employees
- KNSA N/A
- BAK N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- BAK Major Chemicals
- Sector
- KNSA Health Care
- BAK Industrials
- Exchange
- KNSA Nasdaq
- BAK Nasdaq
- Market Cap
- KNSA 2.6B
- BAK 1.3B
- IPO Year
- KNSA 2018
- BAK N/A
- Fundamental
- Price
- KNSA $35.43
- BAK $3.37
- Analyst Decision
- KNSA Strong Buy
- BAK Buy
- Analyst Count
- KNSA 6
- BAK 2
- Target Price
- KNSA $40.83
- BAK $7.50
- AVG Volume (30 Days)
- KNSA 402.6K
- BAK 721.6K
- Earning Date
- KNSA 10-28-2025
- BAK 11-05-2025
- Dividend Yield
- KNSA N/A
- BAK N/A
- EPS Growth
- KNSA N/A
- BAK N/A
- EPS
- KNSA 0.07
- BAK N/A
- Revenue
- KNSA $529,332,000.00
- BAK $14,266,076,929.00
- Revenue This Year
- KNSA $37.21
- BAK $3.02
- Revenue Next Year
- KNSA $11.99
- BAK $10.17
- P/E Ratio
- KNSA $538.95
- BAK N/A
- Revenue Growth
- KNSA 56.18
- BAK 10.48
- 52 Week Low
- KNSA $17.82
- BAK $2.80
- 52 Week High
- KNSA $37.34
- BAK $7.71
- Technical
- Relative Strength Index (RSI)
- KNSA 57.08
- BAK 53.13
- Support Level
- KNSA $35.72
- BAK $3.28
- Resistance Level
- KNSA $37.34
- BAK $3.61
- Average True Range (ATR)
- KNSA 1.01
- BAK 0.11
- MACD
- KNSA -0.12
- BAK -0.00
- Stochastic Oscillator
- KNSA 53.31
- BAK 33.33
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.